Growth hormone receptor holds key to diabetes and cancer

Work on the growth hormone receptor by Queensland researchers will help explain how the  hormone affects a multitude of conditions such as cancer, metabolism and bone turnover as well as growth.

Dr Andrew Brooks and colleagues at the University of Queensland have figured out how growth hormone switches on its receptor at the molecular level, and so now have a clear idea of which part of the molecule to target to design drugs to combat many diseases.

In a report published in Science this week,